BASALIT Example Data File
Just synthetic data from - no relation to BASALIT. Just Placeholder to show how data files can be explored in LDH.
Export PNG
Download
Creators and SubmitterViews: 62 Downloads: 1
Created: 3rd Apr 2023 at 15:58
Last updated: 21st Oct 2024 at 12:05
TagsThis item has not yet been tagged.
AttributionsNone
Version History
Version 2 (latest) Created 21st Oct 2024 at 12:04 by Dr. Frank Meineke
Only synthetic data from - no relation to BASALIT
Version 1 (earliest) Created 3rd Apr 2023 at 15:58 by Dr. Frank Meineke
No revision comments
Related items
Trial Projects:
- BASALIT: Birch Associated Soy Allergy and Immuno-Therapy
- ADIPO-Vent: Optimierung der perioperativen maschinellen Ventilation bei adipösen und normalgewichtigen Patienten durch PEEP-Titration anhand der Elektrischen Impedanz-Tomografie
- GRAFT: Granulocyte colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure
- AbCD: Antibody diagnostics in paediatric Coeliac Disease
- TIBICO: Effectiveness of TNI vs. BiPAP in Chronic Global Insufficiency in COPD Patients
- STOP-NUC: A multicentre randomized controlled trial evaluating the rate of sustained remission and the safety when stopping nucleos(t)ide analogue treatment in non-cirrhotic HBeAg-negative chronic Hepatitis B patients with long-term virologic response
Institutions: Zentrum für Klinische Studien Leipzig (ZKS Leipzig), Universität Leipzig
https://orcid.org/0000-0002-9256-7543
For each clinical trial conducted according to the German Medicines Act (AMG) or the Medical Devices Act (MPG), a sponsor must be named who assumes overall responsibility for the clinical trial. In the case of human clinical trials initiated and managed by staff of the Medical Faculty of the University of Leipzig or Leipzig University Hospital (UKL) (Investigator Initiated Trials; IITs), the University of Leipzig assumes the function of sponsor if no third party is the sponsor.
Trial Projects:
- STOP-NUC: A multicentre randomized controlled trial evaluating the rate of sustained remission and the safety when stopping nucleos(t)ide analogue treatment in non-cirrhotic HBeAg-negative chronic Hepatitis B patients with long-term virologic response
- BASALIT: Birch Associated Soy Allergy and Immuno-Therapy
- ADIPO-Vent: Optimierung der perioperativen maschinellen Ventilation bei adipösen und normalgewichtigen Patienten durch PEEP-Titration anhand der Elektrischen Impedanz-Tomografie
- GRAFT: Granulocyte colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure
- AbCD: Antibody diagnostics in paediatric Coeliac Disease
- TIBICO: Effectiveness of TNI vs. BiPAP in Chronic Global Insufficiency in COPD Patients
A multi centre randomised placebo-controlled double-blind clinical trial for the evaluation of efficacy of specific immunotherapy with an aluminium hydroxide-adsorbed recombinant hypoallergenic derivative of the major birch pollen allergen r Bet v1-FV on Bet v 1 associated soy allergy (Birch Associated Soy Allergy and Immuno-Therapy)
Coordinating investigators: Prof. Dr. Jan C. Simon Prof. Dr. Regina Treudler Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Leipzig ...
Sponsor: Leipzig University (Sponsor)
Public web page: https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011737-27/DE
End date: 18th Jul 2014
